Many investors buy dividend shares for one reason: they want a reliable flow of income.
Some stocks generate larger revenue streams, while others offer more credibility. If you’re looking for both, check out these three dividend stocks.
You can just drool AbbVieNo. (NYSE: ABBV) Dividend yield is close to close. You will almost certainly like the drug manufacturers’ dividend track record. ABVV is a dividend eritocrat – a word S&P 500 Members who have increased their dividends for at least 25 years.
U.S. ABV’s top-selling drug in the market could jeopardize the company’s dividends at the entrance of Humira’s BIOS imilar rmal rivals? I don’t think so. First, the sale of Humira to the U.S. in 2023. Spread in the market will not evaporate completely overnight. More importantly, ABV has a lot of products to generate revenue.
Rinwalk and Skyrizi seem to be the right successors to Humira. ABVV’s blood cancer drugs Imbruvika and Venklexta will be the huge winners. The company’s acquisition of Gan Largan earlier this year gave it several blockbuster franchises, most notably Botox. In addition, ABV’s pipeline features many promising candidates who could take its fortunes down the road.
It is unlikely that Abby will deliver a jaw-dropping income and earnings growth with the challenges ahead for Humira. However, investors should still trust the company’s solid dividends.
2. Brookfield Renewal Partners
Brookfield Renewal Partners (NYSE: BEP)On the other hand, it is a type of stock that offers great dividends along with solid earnings and revenue growth. The company’s dividend yield is currently 3.4% north. Brookfield Renewables has grown at an annual rate of 6% over the last two decades.
Growth should not be a problem for the company. Brookfield Renewal Partners is one of the world’s top providers of renewable energy. It has hydroelectric, solar and wind facilities in four continents. The company can currently generate 18 gigawatts of renewable power but it has a development pipeline that could double its capacity.
Many countries have set aggressive targets for carbon reduction, which benefits renewable power companies such as Brookfield Renewal. It helps that wind and solar are now cheaper sources of bulk power generation, costing even less than natural gas.
Brookfield is an option for renewable partners, which you may also want to consider. Brookfield Renewable Corporation (NYSE: BEPC)There is a similar underlying business but planned as a traditional corporation instead of a limited partnership (LP). This corporate structure eliminates some of the tax issues related to investing in LPs.
3. Innovative Industrial Industrial Properties
If you want a great dividend plus fantastic growth, Innovative Industrial Industrial Properties (NYSE: IIPR) There can only be tickets. Medical Cannabis Real Estate Investment Trust (REIT) has a dividend yield of over 3%. Its stock will almost double in 2020.
IIP has a revenue stream generated from more than 60 medicinal cannabis properties. He usually buys the property from a medical cannabis operator and then leases the property to the operator. As an RIIT, IIP must return at least 90% of its taxable income to shareholders in the form of dividends.
The company should easily continue its solid growth by conducting more sales-leaseback transactions. IIP’s tenants include many of the largest multistate cannabis operators in the U.S. It will not be a surprise if the company expands its relationships with some of these big customers in the near future.
IIPs also have opportunities to expand into additional markets. The company currently owns assets in 16 states, but U.S. With the recent election of, 35 states have now voted to legalize medical cannabis. IIP could be located in the next few years to deliver even more total returns than both Abbey and Brookfield renewable.